Literature DB >> 12507627

Diabetic retinopathy: more than meets the eye.

Thomas W Gardner1, David A Antonetti, Alistair J Barber, Kathryn F LaNoue, Steven W Levison.   

Abstract

Retinal microvascular dysfunction in diabetes is a major component of diabetic retinopathy. This review highlights recent observations regarding the cellular anatomy that contributes to the blood-retinal barrier and its breakdown, the alterations of macroglial, neuronal, and microglial cells in diabetes, and how these changes lead to loss of vision. In addition, the effects of systemic pathophysiologic influences, including metabolic control, blood pressure, and fluid volume on the formation of diabetic macular edema are discussed. Finally, an overview of inflammatory mechanisms and responses in the retina in diabetes is provided. Together, these new observations provide a broader clinical and research perspective on diabetic retinal vascular dysfunction than previously considered, and provide new avenues for improved treatments to prevent loss of vision.

Entities:  

Mesh:

Year:  2002        PMID: 12507627     DOI: 10.1016/s0039-6257(02)00387-9

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  188 in total

Review 1.  Oxidative stress and diabetic neuropathy: a new understanding of an old problem.

Authors:  Eva L Feldman
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.

Authors:  Ahmed S Ibrahim; Mamdouh M El-Shishtawy; Wenbo Zhang; Ruth B Caldwell; Gregory I Liou
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion.

Authors:  M T Cahill; P K Kaiser; J E Sears; S Fekrat
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

Review 4.  New insights into the mechanisms of diabetic neuropathy.

Authors:  Andrea M Vincent; Eva L Feldman
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

5.  Imbalance of the Nerve Growth Factor and Its Precursor: Implication in Diabetic Retinopathy.

Authors:  Riyaz Mohamed; Azza B El-Remessy
Journal:  J Clin Exp Ophthalmol       Date:  2015-10-25

6.  Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.

Authors:  W-Y Shen; C M Lai; C E Graham; N Binz; Y K Y Lai; J Eade; D Guidolin; D Ribatti; S A Dunlop; P E Rakoczy
Journal:  Diabetologia       Date:  2006-05-10       Impact factor: 10.122

7.  Expression of the cystine-glutamate exchanger (xc-) in retinal ganglion cells and regulation by nitric oxide and oxidative stress.

Authors:  Y Dun; B Mysona; T Van Ells; L Amarnath; M Shamsul Ola; V Ganapathy; S B Smith
Journal:  Cell Tissue Res       Date:  2006-01-28       Impact factor: 5.249

8.  MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.

Authors:  Ying Wang; Wenwen Lin; Jianghua Ju
Journal:  Cell Cycle       Date:  2020-04-15       Impact factor: 4.534

9.  Roles of Wnt/β-catenin signaling in retinal neuron-like differentiation of bone marrow mesenchymal stem cells from nonobese diabetic mice.

Authors:  Xu Yue; Gu Zhifeng; Shen Biyu; Xu Guofeng; Zhou Tianqiu; Jiang Jinxia; Xing Jing; Liu Suzhe; Li Man; Tan Wei; Feng Guijuan; Sang Aimin; Li Liren
Journal:  J Mol Neurosci       Date:  2012-11-16       Impact factor: 3.444

10.  TGFβ induces BIGH3 expression and human retinal pericyte apoptosis: a novel pathway of diabetic retinopathy.

Authors:  B S Betts-Obregon; A A Mondragon; A S Mendiola; R G LeBaron; R Asmis; T Zou; F Gonzalez-Fernandez; A T Tsin
Journal:  Eye (Lond)       Date:  2016-08-26       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.